This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. shed 2.9% to $6.30 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.1% to 19,546.27 and the Dow Jones Industrial Average falling 0.1% to 42,171.66.
This was the stock's second consecutive day of losses.
Novavax Inc. closed 64.6% below its 52-week high of $17.81, which the company achieved on July 26th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 1.1% to $150.73, Pfizer Inc. fell 0.5% to $23.88, and Merck & Co. Inc. rose 1.29% to $79.29.
Trading volume totaled 6.4 million, compared to the 50-day average of 9.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 18, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。